Trial intelligence / Profile preview

Weekly Paclitaxel in Advanced Ovarian Cancer

NCT00002928Phase 2Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Jan 1997
Primary completion
Aug 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel in ovarian cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 1997; status: completed.

02

Drugs

paclitaxel
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT00002928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call